Application Nr Approved Date Route Status External Links
ANDA090055 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Renal, Cardiac, And Hepatic Transplant Mycophenolate Mofetil Is Indicated For The Prophylaxis Of Organ Rejection In Patients Receiving Allogeneic Renal, Cardiac Or Hepatic Transplants. Mycophenolate Mofetil Should Be Used Concomitantly With Cyclosporine And Corticosteroids. Mycophenolate Mofetil Intravenous Is An Alternative Dosage Form To Mycophenolate Mofetil Tablets, Capsules And Oral Suspension. Mycophenolate Mofetil Intravenous Should Be Administered Within 24 Hours Following Transplantation. Mycophenolate Mofetil Intravenous Can Be Administered For Up To 14 Days; Patients Should Be Switched To Oral Mycophenolate Mofetil As Soon As They Can Tolerate Oral Medication.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mycophenolate Mofetil

Comments